Protara Therapeutics, Inc.

TARA

—

Advanced chart & tools →

Protara Therapeutics, Inc.TARA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.34

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$2.95M

Net income

$-57.44M

Net margin

-1948.4%

Gross margin

—

Dividends & financials

Protara Therapeutics, Inc. (TARA) reported revenue of $2.95M and net income of $-57.44M, or $-1.34 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.